bcbs michigan glp-1 BCBSM pulling back on coverage Why Blue Cross Blue Shield
Description
The incretin hormones gastric inhibitory polypeptide and especially glucagon-like peptide (GLP) have an important physiological function in augmenting postprandial insulin secretion
- Not recommended for individuals with severe digestive disorders
Time-to-onset analysis revealed a median latency of 32 days (IQR 7122) for GLP-1 RA-related NAEs, with 45.28% occurring within 30 days of treatment initiation
The approval pertains to the GLP-1 drug dubbed Xianweiying also known as ecnoglutide which Pfizer has just acquired in a billion-dollar deal.
Learn how this medical weight management option may work for you.
Super gut-friendly formulas
